相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Lauren B. Rodda et al.
CELL (2021)
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Drew Weissman et al.
CELL HOST & MICROBE (2021)
Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
Daniel Poston et al.
CLINICAL INFECTIOUS DISEASES (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Persistence of IgG response to SARS-CoV-2
Els Duysburgh et al.
LANCET INFECTIOUS DISEASES (2021)
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler et al.
NATURE (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant
Eric J. Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Zijun Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals
Jian Zhang et al.
NATURE MICROBIOLOGY (2021)
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Aurelien Sokal et al.
CELL (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Emergence of a Novel SARS-CoV-2 Variant in Southern California
Wenjuan Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
Sixteen novel lineages of SARS-CoV-2 in South Africa
Houriiyah Tegally et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2021)
Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India
Pragya D. Yadav et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
Tracking the emergence of new SARS-CoV-2 variants in South Africa
Anise N. Happi et al.
NATURE MEDICINE (2021)
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song et al.
NATURE COMMUNICATIONS (2021)
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
Jing Zou et al.
NPJ VACCINES (2021)
Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan
Yosuke Hirotsu et al.
JOURNAL OF INFECTION (2021)
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
Carolina Kymie Vasques Nonaka et al.
EMERGING INFECTIOUS DISEASES (2021)
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan
Takahisa Fujino et al.
EMERGING INFECTIOUS DISEASES (2021)
Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020
Ingra Morales Claro et al.
EMERGING INFECTIOUS DISEASES (2021)
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
Bas B. Oude Munnink et al.
SCIENCE (2021)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review
Riccardo Castagnoli et al.
JAMA PEDIATRICS (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo et al.
IMMUNITY (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Matthew C. Woodruff et al.
NATURE IMMUNOLOGY (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
Phuong Nguyen-Contant et al.
MBIO (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals
Yuanmei Zhu et al.
SCIENCE ADVANCES (2020)
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
Mar Masia et al.
EBIOMEDICINE (2020)
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
Tomer Zohar et al.
CELL (2020)
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
Anwar M. Hashem et al.
VIRUSES-BASEL (2020)
Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil
Marcelo Henrique Santos Paiva et al.
VIRUSES-BASEL (2020)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Katharina Roltgen et al.
SCIENCE IMMUNOLOGY (2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng et al.
SCIENCE (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
Gemma E. Hartley et al.
SCIENCE IMMUNOLOGY (2020)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)